What cancer care leaders need to see before the next quarter

Cancer organizations are being asked to move faster while making decisions with more accountability. That tension is not solved by adding another dashboard.

Visibility is an operating capability.

When referral, treatment, outcomes, and research signals stay in separate places, teams spend time reconciling the picture before they can improve it. A tumor board meeting opens with ten minutes of comparing spreadsheets instead of ten minutes of deciding what to do about a stalled pathway.

Leaders do not need more charts. They need one shared, trusted account of what is happening across the pathway right now — who is waiting, where capacity is tight, and which cases are at risk of falling through.

Three questions every quarterly review should be able to answer.

Before the next leadership review, it is worth testing whether your current reporting can answer three plain questions: Where exactly is time being lost between referral and first treatment? Which patient cohorts are under-followed relative to protocol? And which sites in the network are quietly outperforming or underperforming their peers?

If the honest answer involves someone manually reconciling three systems, that is the gap worth closing first — not a new initiative, just a clearer view of the one you already run.

Start with a question that has an owner.

The best intelligence products begin with a practical question and a measurable baseline. A focused MVP creates trust by answering one question exceptionally well, then earns the right to answer the next one.